Endo International
ENDPQ
$0.0006000
Share price
0.00%
Change (1 day)
-99.14%
Change (1 year)
Categories
P/S ratio for Endo International (ENDPQ)
P/S ratio as of April 2024 (TTM): 0.0001
According to Endo International 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.01619E-5. At the end of 2023 the company had a P/S ratio of 0.0001.
P/S ratio history for Endo International from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.0001 | -99.19% |
| 2022 | 0.0072 | -97.55% |
| 2021 | 0.2936 | -48.46% |
| 2020 | 0.5696 | 56.07% |
| 2019 | 0.3650 | -34.33% |
| 2018 | 0.5558 | 11.4% |
| 2017 | 0.4989 | -45.49% |
| 2016 | 0.9153 | -78% |
| 2015 | 4.16 | -5.64% |
| 2014 | 4.41 | 39.31% |
| 2013 | 3.16 | 229.68% |
| 2012 | 0.9600 | -35.04% |
| 2011 | 1.48 | -38.81% |
| 2010 | 2.41 | 46.6% |
| 2009 | 1.65 | -40.23% |
| 2008 | 2.76 | -16.37% |
| 2007 | 3.30 | -18.64% |
| 2006 | 4.05 | -17.33% |
| 2005 | 4.90 | 8.79% |
| 2004 | 4.50 | 5.15% |
| 2003 | 4.28 | 117.47% |
| 2002 | 1.97 | -58.33% |
| 2001 | 4.73 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 Cara Therapeutics
CARA | 1.75 | 2,495,513.72% | 🇺🇸 USA |